Christian Scherrer

Senior Investment Director

Employed: 2014

Based: London

Board positions: Enveda, Spring Health,, Cityblock Health (observer), Transcarent (observer),

Shareholding (including closely affiliated persons): 20,720 class B-shares

Incentive Shares: 163,032 (2024-29), 76,820 (2023-2028), 43,000 (2022-27), 28,378 (2021-2026), 33,600 (2020-25)

Christian joined Kinnevik in 2014 in their London office after kickstarting his career at JP Morgan in technology and media investment banking. Since joining Kinnevik, Christian built a sizeable healthcare portfolio, starting from zero to today over a third of Kinnevik's asset base. He helped craft and execute the healthcare strategy, investing nearly USD1 billion into healthcare services and technology companies in the US and Europe.

An early investor in leading healthcare companies like Livongo (acquired by TDOC), VillageMD (acquired by WBA), Cityblock, Cedar, Transcarent and Spring Health, Christian has also spearheaded Kinnevik’s investments in biotech, leading a significant PIPE investment in Recursion (RXRX) and a private investment in Enveda Biosciences.